Literature DB >> 21155989

Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.

A Splichalova1, I Trebichavsky, V Rada, E Vlkova, U Sonnenborn, I Splichal.   

Abstract

The colonization, translocation and protective effect of two intestinal bacteria - PR4 (pig commensal strain of Bifidobacterium choerinum) or EcN (probiotic Escherichia coli strain Nissle 1917) - against subsequent infection with a virulent LT2 strain of Salmonella enterica serovar Typhimurium were studied in gnotobiotic pigs after oral association. The clinical state of experimental animals correlated with bacterial translocation and levels of inflammatory cytokines [a chemokine, interleukin (IL)-8, a proinflammatory cytokine, tumour necrosis factor (TNF)-α and an anti-inflammatory cytokine, IL-10] in plasma and intestinal lavages. Gnotobiotic pigs orally mono-associated with either PR4 or EcN thrived, and bacteria were not found in their blood. No significant inflammatory cytokine response was observed. Mono-association with Salmonella caused devastating septicaemia characterized by high levels of IL-10 and TNF-α in plasma and TNF-α in the intestine. Di-associated gnotobiotic pigs were given PR4 or EcN for 24 h. Subsequently, they were infected orally with Salmonella and euthanized 24 h later. Pigs associated with bifidobacteria before Salmonella infection suffered from severe systemic infection and mounted similar cytokine responses as pigs infected with Salmonella alone. In contrast, EcN interfered with translocation of Salmonella into mesenteric lymph nodes and systemic circulation. Pigs pre-associated with EcN thrived and their clinical condition correlated with the absence of IL-10 in their plasma and a decrease of TNF-α in plasma and ileum.
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21155989      PMCID: PMC3043315          DOI: 10.1111/j.1365-2249.2010.04283.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

Review 1.  Foodborne illness: is it on the rise?

Authors:  David G Nyachuba
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

2.  Effects of feeding antibiotic-free creep feed supplemented with oligofructose, probiotics or synbiotics to suckling piglets increases the preweaning weight gain and composition of intestinal microbiota.

Authors:  S B Shim; M W A Verstegen; I H Kim; O S Kwon; J M A J Verdonk
Journal:  Arch Anim Nutr       Date:  2005-12       Impact factor: 2.242

Review 3.  Cross-talk of human gut with bifidobacteria.

Authors:  Ilja Trebichavsky; Vojtech Rada; Alla Splichalova; Igor Splichal
Journal:  Nutr Rev       Date:  2009-02       Impact factor: 7.110

4.  The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession.

Authors:  G Reuter
Journal:  Curr Issues Intest Microbiol       Date:  2001-09

Review 5.  Non-typhoidal salmonella bacteraemia--an under-recognized feature of AIDS in African adults.

Authors:  Anstead M Kankwatira; Gershom A K Mwafulirwa; Melita A Gordon
Journal:  Trop Doct       Date:  2004-10       Impact factor: 0.731

6.  Salmonellosis: lessons drawn from a germ-free pig model.

Authors:  I Trebichavský; J Schulze; V Dlabac; B Cukrowska; H Tlaskalová-Hogenová; Z Reháková
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

7.  A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Laura E J Searle; Angus Best; Alejandro Nunez; Francisco J Salguero; Linda Johnson; Ute Weyer; Alexandra H Dugdale; William A Cooley; Ben Carter; Gareth Jones; George Tzortzis; Martin J Woodward; Roberto M La Ragione
Journal:  J Med Microbiol       Date:  2009-01       Impact factor: 2.472

Review 8.  Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues.

Authors:  Pietro Mastroeni; Mark Sheppard
Journal:  Microbes Infect       Date:  2004-04       Impact factor: 2.700

9.  Development and application of a pig IL-8 ELISA detection system.

Authors:  I Splichal; Y Muneta; Y Mori; E Takahashi
Journal:  J Immunoassay Immunochem       Date:  2003

10.  The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.

Authors:  Artur Altenhoefer; Sibylle Oswald; Ulrich Sonnenborn; Corinne Enders; Juergen Schulze; Joerg Hacker; Tobias A Oelschlaeger
Journal:  FEMS Immunol Med Microbiol       Date:  2004-04-09
View more
  17 in total

1.  Alarmin HMGB1 is released in the small intestine of gnotobiotic piglets infected with enteric pathogens and its level in plasma reflects severity of sepsis.

Authors:  Alla Splichalova; Igor Splichal; Petra Chmelarova; Ilja Trebichavsky
Journal:  J Clin Immunol       Date:  2011-01-12       Impact factor: 8.317

2.  Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model.

Authors:  Gregory O'Connor; Elisabeth Jeffrey; Derik Madorma; Alexander Marcillo; Maria T Abreu; Sapna K Deo; W Dalton Dietrich; Sylvia Daunert
Journal:  J Neurotrauma       Date:  2018-06-07       Impact factor: 5.269

3.  Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens.

Authors:  Yosra A Helmy; Gary Closs; Kwonil Jung; Dipak Kathayat; Anastasia Vlasova; Gireesh Rajashekara
Journal:  Infect Immun       Date:  2022-09-22       Impact factor: 3.609

4.  Phylogenetic diversity analysis of shotgun metagenomic reads describes gut microbiome development and treatment effects in the post-weaned pig.

Authors:  Daniela Gaio; Matthew Z DeMaere; Kay Anantanawat; Graeme J Eamens; Linda Falconer; Toni A Chapman; Steven Djordjevic; Aaron E Darling
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

5.  Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.

Authors:  Anastasia N Vlasova; Lulu Shao; Sukumar Kandasamy; David D Fischer; Abdul Rauf; Stephanie N Langel; Kuldeep S Chattha; Anand Kumar; Huang-Chi Huang; Gireesh Rajashekara; Linda J Saif
Journal:  Eur J Immunol       Date:  2016-08-11       Impact factor: 5.532

6.  Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron.

Authors:  Elisa Deriu; Janet Z Liu; Milad Pezeshki; Robert A Edwards; Roxanna J Ochoa; Heidi Contreras; Stephen J Libby; Ferric C Fang; Manuela Raffatellu
Journal:  Cell Host Microbe       Date:  2013-07-17       Impact factor: 21.023

7.  Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.

Authors:  Yanlong Jiang; Qingke Kong; Kenneth L Roland; Amanda Wolf; Roy Curtiss
Journal:  Pathog Dis       Date:  2014-03-11       Impact factor: 3.166

8.  Impacts of canine distemper virus infection on the giant panda population from the perspective of gut microbiota.

Authors:  Na Zhao; Meng Li; Jing Luo; Supen Wang; Shelan Liu; Shan Wang; Wenting Lyu; Lin Chen; Wen Su; Hua Ding; Hongxuan He
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

Review 9.  Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections.

Authors:  Sukumar Kandasamy; Anastasia N Vlasova; David D Fischer; Kuldeep S Chattha; Lulu Shao; Anand Kumar; Stephanie N Langel; Abdul Rauf; Huang-Chi Huang; Gireesh Rajashekara; Linda J Saif
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

Review 10.  Salmonella versus the Microbiome.

Authors:  Andrew W L Rogers; Renée M Tsolis; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2020-12-23       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.